These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28101123)

  • 41. Advanced glycation end products: A link between metabolic and endothelial dysfunction in polycystic ovary syndrome?
    Pertynska-Marczewska M; Diamanti-Kandarakis E; Zhang J; Merhi Z
    Metabolism; 2015 Nov; 64(11):1564-73. PubMed ID: 26386695
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Irbesartan treatment does not influence plasma levels of the advanced glycation end products N(epsilon)(1-carboxymethyl)lysine and N(epsilon)(1-carboxyethyl)lysine in patients with type 2 diabetes and microalbuminuria. A randomized controlled trial.
    Engelen L; Persson F; Ferreira I; Rossing P; Hovind P; Teerlink T; Stehouwer CD; Parving HH; Schalkwijk CG
    Nephrol Dial Transplant; 2011 Nov; 26(11):3573-7. PubMed ID: 21385863
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Redox Balance, Antioxidant Defense, and Oxidative Damage in the Hypothalamus and Cerebral Cortex of Rats with High Fat Diet-Induced Insulin Resistance.
    Maciejczyk M; Żebrowska E; Zalewska A; Chabowski A
    Oxid Med Cell Longev; 2018; 2018():6940515. PubMed ID: 30271528
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dietary glycotoxins affect scavenger receptor expression and the hormonal profile of female rats.
    Chatzigeorgiou A; Kandaraki E; Piperi C; Livadas S; Papavassiliou AG; Koutsilieris M; Papalois A; Diamanti-Kandarakis E
    J Endocrinol; 2013 Sep; 218(3):331-7. PubMed ID: 23823020
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diet-derived advanced glycation end products or lipofuscin disrupts proteostasis and reduces life span in Drosophila melanogaster.
    Tsakiri EN; Iliaki KK; Höhn A; Grimm S; Papassideri IS; Grune T; Trougakos IP
    Free Radic Biol Med; 2013 Dec; 65():1155-1163. PubMed ID: 23999505
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dietary glycotoxins exacerbate progression of experimental fatty liver disease.
    Leung C; Herath CB; Jia Z; Goodwin M; Mak KY; Watt MJ; Forbes JM; Angus PW
    J Hepatol; 2014 Apr; 60(4):832-8. PubMed ID: 24316518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy.
    Tan AL; Sourris KC; Harcourt BE; Thallas-Bonke V; Penfold S; Andrikopoulos S; Thomas MC; O'Brien RC; Bierhaus A; Cooper ME; Forbes JM; Coughlan MT
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F763-70. PubMed ID: 20015941
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ankaflavin: a natural novel PPARγ agonist upregulates Nrf2 to attenuate methylglyoxal-induced diabetes in vivo.
    Lee BH; Hsu WH; Chang YY; Kuo HF; Hsu YW; Pan TM
    Free Radic Biol Med; 2012 Dec; 53(11):2008-16. PubMed ID: 23022408
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel Inhibitory Effects of Glycyrrhizic Acid on the Accumulation of Advanced Glycation End Product and Its Receptor Expression.
    Cheng HS; Kong JM; Ng AX; Chan WK; Ton SH; Abdul Kadir K
    Nat Prod Bioprospect; 2014 Dec; 4(6):325-33. PubMed ID: 25369772
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ursolic acid and rosiglitazone combination alleviates metabolic syndrome in high fat diet fed C57BL/6J mice.
    Sundaresan A; Harini R; Pugalendi KV
    Gen Physiol Biophys; 2012 Sep; 31(3):323-33. PubMed ID: 23047945
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glycyrrhizin ameliorates metabolic syndrome-induced liver damage in experimental rat model.
    Sil R; Ray D; Chakraborti AS
    Mol Cell Biochem; 2015 Nov; 409(1-2):177-89. PubMed ID: 26400710
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of diet-induced obesity in male mouse reproductive system: The role of advanced glycation end product-receptor for advanced glycation end product axis.
    Moschonas DP; Piperi C; Korkolopoulou P; Levidou G; Kavantzas N; Trigka EA; Vlachos I; Arapostathi C; Perrea D; Mitropoulos D; Diamanti-Kandarakis E; Papavassiliou AG
    Exp Biol Med (Maywood); 2014 Aug; 239(8):937-947. PubMed ID: 24872429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antioxidant and anti hyperglycemic role of wine grape powder in rats fed with a high fructose diet.
    Hernández-Salinas R; Decap V; Leguina A; Cáceres P; Perez D; Urquiaga I; Iturriaga R; Velarde V
    Biol Res; 2015 Sep; 48():53. PubMed ID: 26420015
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial.
    Vlassara H; Cai W; Tripp E; Pyzik R; Yee K; Goldberg L; Tansman L; Chen X; Mani V; Fayad ZA; Nadkarni GN; Striker GE; He JC; Uribarri J
    Diabetologia; 2016 Oct; 59(10):2181-92. PubMed ID: 27468708
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Total plasma Nε-(carboxymethyl)lysine and sRAGE levels are inversely associated with a number of metabolic syndrome risk factors in non-diabetic young-to-middle-aged medication-free subjects.
    Sebeková K; Krivošíková Z; Gajdoš M
    Clin Chem Lab Med; 2014 Jan; 52(1):139-49. PubMed ID: 23509221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dietary sardine protein lowers insulin resistance, leptin and TNF-α and beneficially affects adipose tissue oxidative stress in rats with fructose-induced metabolic syndrome.
    Madani Z; Louchami K; Sener A; Malaisse WJ; Ait Yahia D
    Int J Mol Med; 2012 Feb; 29(2):311-8. PubMed ID: 22085913
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study.
    Bijnen M; van Greevenbroek MMJ; van der Kallen CJH; Scheijen JL; van de Waarenburg MPH; Stehouwer CDA; Wouters K; Schalkwijk CG
    J Diabetes Res; 2019; 2019():6289831. PubMed ID: 31218233
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Attenuation of hypertension development by scavenging methylglyoxal in fructose-treated rats.
    Wang X; Jia X; Chang T; Desai K; Wu L
    J Hypertens; 2008 Apr; 26(4):765-72. PubMed ID: 18327087
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats.
    Bagul PK; Middela H; Matapally S; Padiya R; Bastia T; Madhusudana K; Reddy BR; Chakravarty S; Banerjee SK
    Pharmacol Res; 2012 Sep; 66(3):260-8. PubMed ID: 22627169
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term administration of advanced glycation end-product stimulates the activation of NLRP3 inflammasome and sparking the development of renal injury.
    Yeh WJ; Yang HY; Pai MH; Wu CH; Chen JR
    J Nutr Biochem; 2017 Jan; 39():68-76. PubMed ID: 27816762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.